[HTML][HTML] Lysine Methyltransferase 9 (KMT9) Is an Actionable Target in Muscle-Invasive Bladder Cancer

S Totonji, A Ramos-Triguero, D Willmann, M Sum… - Cancers, 2024 - mdpi.com
Simple Summary The recently identified lysine methyltransferase (KMT) 9 regulates the
growth of different types of cancer. While KMT9 was shown to be overexpressed in muscle …

[HTML][HTML] Lysine Methyltransferase 9 (KMT9) Is an Actionable Target in Muscle-Invasive Bladder Cancer

S Totonji, A Ramos-Triguero, D Willmann, M Sum… - Cancers, 2024 - ncbi.nlm.nih.gov
Novel treatment modalities are imperative for the challenging management of muscle-
invasive and metastatic BC to improve patient survival rates. The recently identified KMT9 …

Lysine Methyltransferase 9 (KMT9) Is an Actionable Target in Muscle-Invasive Bladder Cancer

S Totonji, A Ramos-Triguero, D Willmann… - …, 2024 - pubmed.ncbi.nlm.nih.gov
Novel treatment modalities are imperative for the challenging management of muscle-
invasive and metastatic BC to improve patient survival rates. The recently identified KMT9 …

Lysine Methyltransferase 9 (KMT9) Is an Actionable Target in Muscle-Invasive Bladder Cancer.

S Totonji, A Ramos-Triguero, D Willmann, M Sum… - Cancers, 2024 - europepmc.org
Novel treatment modalities are imperative for the challenging management of muscle-
invasive and metastatic BC to improve patient survival rates. The recently identified KMT9 …

Lysine Methyltransferase 9 (KMT9) Is an Actionable Target in Muscle-Invasive Bladder Cancer.

S Totonji, A Ramos-Triguero, D Willmann, M Sum… - …, 2024 - search.ebscohost.com
Abstract Simple Summary: The recently identified lysine methyltransferase (KMT) 9
regulates the growth of different types of cancer. While KMT9 was shown to be …